Emerging Biotherapeutics in India: Opportunities and Evolving Regulations in Cell and Gene Therapies

10:30 AM - 12:00 PM, Thursday, June 6,2019 ・ 115B, Level 100
India is looking to regulate cell and gene therapies as drugs. The panel of experts will discuss their current proposed draft of Regulatory Guidelines on Gene and Cell Therapy Drugs as well as their experience of developing bio therapeutics, including early stage CAR-T companies in India. What can India learn from other countries’ regulations while taking into consideration general challenges that governments’ should be aware of during the process? What experiences can be shared from companies who are currently developing products in this space?
Speakers
photo
Associate Director, Global Regulatory Affairs
Janssen
photo
President
Lupin Limited
photo
Managing Director & CEO
Stempeutics Research Pvt. Ltd.
photo
Chief Commercial Officer
Syngene International Ltd.
photo
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
photo
SVP - Scientific and Medical Affairs
Navitas Life Sciences